COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
View ORCID ProfileGiulia Vivaldi, View ORCID ProfileMohammad Talaei, Paul E Pfeffer, Seif O Shaheen, View ORCID ProfileAdrian R Martineau
doi: https://doi.org/10.1101/2024.06.28.24309666
Giulia Vivaldi
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mohammad Talaei
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Paul E Pfeffer
3Department of Respiratory Medicine, Barts Health NHS Trust, London, UK
4William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Seif O Shaheen
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
5Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia
Adrian R Martineau
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
6Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK

Data Availability
De-identified participant data will be made available upon reasonable request to the corresponding author.
Posted June 30, 2024.
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Giulia Vivaldi, Mohammad Talaei, Paul E Pfeffer, Seif O Shaheen, Adrian R Martineau
medRxiv 2024.06.28.24309666; doi: https://doi.org/10.1101/2024.06.28.24309666
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Giulia Vivaldi, Mohammad Talaei, Paul E Pfeffer, Seif O Shaheen, Adrian R Martineau
medRxiv 2024.06.28.24309666; doi: https://doi.org/10.1101/2024.06.28.24309666
Subject Area
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3067)
- Dermatology (259)
- Emergency Medicine (460)
- Epidemiology (12996)
- Forensic Medicine (13)
- Gastroenterology (857)
- Genetic and Genomic Medicine (4806)
- Geriatric Medicine (443)
- Health Economics (749)
- Health Informatics (3043)
- Health Policy (1100)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (497)
- Neurology (4582)
- Nursing (243)
- Nutrition (680)
- Oncology (2377)
- Ophthalmology (671)
- Orthopedics (267)
- Otolaryngology (332)
- Pain Medicine (299)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1235)
- Primary Care Research (517)
- Public and Global Health (7161)
- Radiology and Imaging (1592)
- Respiratory Medicine (941)
- Rheumatology (458)
- Sports Medicine (400)
- Surgery (507)
- Toxicology (64)
- Transplantation (218)
- Urology (188)